The China Study by Thomas Campbell
- Heber 0, Ashley JM, LeafDA, et at. "Reduction of serum estradiol in postmenopausal women
given free access to low-fat high-carbohydrate diet." Nutrition 7 (1991): 137-139.
- Rose DP, Goldman M, Connolly JM, et al. "High-fiber diet reduces serum estrogen concentra-
tions in premenopausal women." Am.]. Clin. Nutr. 54 (1991): 520-525.
- Rose DP, Lubin M, and Connolly JM. "Efects of diet supplementation with wheat bran on
serum estrogen levels in the follicular and luteal phases of the menstrual cycle." Nutrition 13
- Tymchuk CN, Tessler SB, and Barnard R]. "Changes in sex hormone-binding globulin, insu-
lin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with
exercise." Nutr. Cancer 38 (2000): 158-162.
- Key TJA, ChenJ, Wang DY, et a1. "Sex hormones in women in rural China and in Britain."
Brit.]. Cancer 62 (1990): 631-636.
- Prentice R, Thompson 0 , Clifford C, et at. "Dietary fat reduction and plasma estradiol con-
centration in healthy postmenopausal women."]. Natl. Cancer Inst. 82 (1990): 129-134.
- Boyar Ap, Rose Dp, and Wynder EL. "Recommendations for the prevention of chronic disease:
the application for breast disease." Am.]. Clin. Nutr. 48(3 Suppl) (1988): 896--900.
- Nandi S, Guzman RC, and Yang]. "Hormones and mammary carcinogenesis in mice, rats and
humans: a unifying hypothesis." Proc. National Acad. Sci 92 (1995): 3650-3657.
- Peto J, Easton OF, Matthews FE, et al. "Cancer mortality in relatives of women with breast
cancer, the OPCS study." Int.]. Cancer 65 (1996): 275-283.
- Colditz GA, Willett W, Hunter OJ, et at. "Family history, age, and risk of breast cancer. Pro-
spective data from the Nurses' Health Study." lAMA 270 (1993): 338-343.
- National Human Genome Research Institute. "Learning About Breast Cancer." Accessed at
- Futreal PA, Liu Q , Shattuck-Eidens 0 , et al. "BRCAI mutations in primary breast and ovarian
carcinomas." Science 266 (1994): 120-122.
- Miki Y, SwensenJ, Shatttuck-Eidens 0, et al. "A strong candidate for the breast and ovarian
cancer susceptibility gene BRCA1." Science 266 (1994): 66--71.
- Wooster R, Bignell G, Lancaster J, et al. "Identification ofthe breast cancer susceptibility gene
BRCA2." Nature 378 (1995): 789-792.
- Tavtigian Sv, Simard J , Rommens J, et al. "The complete BRCA2 gene and mutations in chro-
mosome 13q-linked kindreds." Nat. Genet. 12 (1996): 333-337.
- Ford 0, Easton 0, Bishop DT, et al. "Risks of cancer in BRCAI mutation carriers." Lancet 343
- Antoniou A, Pharoah PDp, Narod S, et at. "Average risks of breast and ovarian cancer associ-
ated with BRCAI or BRCA2 mutations detected in case series unselected for family history: a
combined analysis of 22 studies." Am. ]. Hum. Genet. 72 (2003): 1117-1130.
- Newman B, Mu H, Butler LM, et al. "Frequency of breast cancer attributable to BRCAI in a
population-based series of American women." lAMA 279 (1998): 915-921.
- Peto], Collins N, Barfoot R, et al. "Prevalence of BRCAI and BRCA2 gene mutations in pa-
tients with early-onset breast cancer."]. Nat. Cancer Inst. 91 (1999): 943-949.
- Tabar L, Fagerberg G, Chen HH, et al. "Efficacy of breast cancer screening by age. New results
from the Swedish Two-County Trial." Cancer 75 (1995): 2507-2517.
- Bjurstram N, Bjomeld L, Duffy Sw, et a1. "The Gothenburg Breast Cancer Screening Trial:
first results on mortality, incidence, and mode of detection for women ages 39-49 years at
randomization." Cancer 80 (1997): 2091-2099.
- Frisell J, Lidbrink E, Hellstrom L, et at. "Follow-up after 11 years: update of mortality results
in the Stockholm mammographic screening trial." Breast Cancer Res. Treat 199745 (1997):
- Greenlee RT, Hill-Harmon MB, Murray T, et at. "Cancer statistics, 2001." CA Cancer]. Clin.
51 (2001): 15-36.